SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Josh C. Pleasure, M.D. who wrote (147)6/3/1997 9:08:00 PM
From: David B. Higgs   of 371
 
Dr. Pleasure

As someone who barely passed high school biology many years ago, I appreciate your translation in laymen's terms the significance of the recent flurry of news releases.

Based on your medical and investment experience, your opinion of the meaning of today's pullback would be appreciated. It appears from your post, two things happened today, namely; a positive press release concerning non-Hodgkin's lymphoma and a less than positive presentation on CEA/thyroid cancer. The result was a significant pull back of the gains of the last few days.

Is the market so sophisticated so as to incorporate today's presentation into today's valuation? Was today's presentation available to certain financial organizations in advance? Or, was today's drop only profit taking by those who brought in during the last few months when Immunomedics was trading in the low 4 dollar range? Your opinion would be appreciated.

Thanks
Dave

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext